BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16598285)

  • 1. Protein twists and turns in Alzheimer disease.
    Maudsley S; Mattson MP
    Nat Med; 2006 Apr; 12(4):392-3. PubMed ID: 16598285
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the understanding of the processing of APP to beta amyloid peptide.
    Sinha S; Anderson J; John V; McConlogue L; Basi G; Thorsett E; Schenk D
    Ann N Y Acad Sci; 2000; 920():206-8. PubMed ID: 11193151
    [No Abstract]   [Full Text] [Related]  

  • 3. Pin-pointing APP processing.
    Willnow TE; Andersen OM
    Mol Interv; 2006 Jun; 6(3):137-9. PubMed ID: 16809474
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroscience. An accomplice for gamma-secretase brought into focus.
    Sisodia SS
    Science; 2000 Sep; 289(5488):2296-7. PubMed ID: 11041797
    [No Abstract]   [Full Text] [Related]  

  • 5. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of beta-secretase.
    Stephens DJ; Austen BM
    Biochem Soc Trans; 1998 Aug; 26(3):500-4. PubMed ID: 9765904
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell biological perspective on Alzheimer's disease.
    Annaert W; De Strooper B
    Annu Rev Cell Dev Biol; 2002; 18():25-51. PubMed ID: 12142279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Arctic mutation interferes with processing of the amyloid precursor protein.
    Stenh C; Nilsberth C; Hammarbäck J; Engvall B; Näslund J; Lannfelt L
    Neuroreport; 2002 Oct; 13(15):1857-60. PubMed ID: 12395079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
    Selkoe DJ
    J Clin Invest; 2002 Nov; 110(10):1375-81. PubMed ID: 12438432
    [No Abstract]   [Full Text] [Related]  

  • 11. Pin1 flips Alzheimer's switch.
    Etzkorn FA
    ACS Chem Biol; 2006 May; 1(4):214-6. PubMed ID: 17163675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying proteases that cleave APP.
    Citron M
    Ann N Y Acad Sci; 2000; 920():192-6. PubMed ID: 11193149
    [No Abstract]   [Full Text] [Related]  

  • 13. Transgenic mouse models of Alzheimer's disease.
    Janus C; Chishti MA; Westaway D
    Biochim Biophys Acta; 2000 Jul; 1502(1):63-75. PubMed ID: 10899432
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease: Mental plaque removal.
    De Strooper B; Woodgett J
    Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
    [No Abstract]   [Full Text] [Related]  

  • 15. Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?
    Murphy MP; Golde TE
    Neurology; 2006 Jan; 66(2 Suppl 1):S65-8. PubMed ID: 16432148
    [No Abstract]   [Full Text] [Related]  

  • 16. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new BACE is for therapy of Alzheimer's disease.
    Kahana J
    Trends Cell Biol; 2001 May; 11(5):192. PubMed ID: 11316595
    [No Abstract]   [Full Text] [Related]  

  • 18. Processing and secretion of Alzheimer's disease amyloid precursor protein.
    Kinbara K; Kitagaki H; Kinouchi T; Okano M; Sorimachi H; Ishiura S; Suzuki K
    Tohoku J Exp Med; 1994 Nov; 174(3):209-16. PubMed ID: 7761986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess betaCTF, not Abeta: the culprit in Alzheimer-related endocytic dysfunction.
    Griffin WS
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1263-4. PubMed ID: 20133888
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.